Publications by authors named "S Benkhalifa"

Claim this Profile
P
Physicochemical stability of a bevacizumab biosimilar in vials and diluted preparations: Implications for hospital practice and inventory management.
Victoire Vieillard, Lucile Foulley, Salim Benkhalifa, Muriel Paul

Ann Pharm Fr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations.
Jérôme Avouac, Hafid Ait-Oufella, Caroline Habauzit, Salim Benkhalifa, Bernard Combe

Rheumatol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study.
Guillaume Bouguen, Laure Gossec, Vered Abitbol, Eric Senbel, Guillaume Bonnaud, Salim Benkhalifa

BioDrugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating adalimumab biosimilars: an expert opinion.
Vered Abitbol, Salim Benkhalifa, Caroline Habauzit, Hubert Marotte

J Comp Eff Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.
Ferdinando D'Amico, Laurent Peyrin-Biroulet, Luc Vandromme, Yoram Bouhnik, Patrick Faure, Salim Benkhalifa

Dig Liver Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis